To analyse in vivo biglycan expression in TECs, we performed immunofluorescent double staining with anti-CD31 and anti-biglycan antibodies in the frozen sections of 11 human malignant tumours; 6 from kidneys, 3 from lungs, 1 from colon and 1 from liver. Here, PECAM1 is linked to cancer.